semaglutide criteria What are the prescribing for oral (Rybelsus) for weight loss in adults, including BMI thresholds, required comorbidities, contraindications, and dosing schedule? Baseline characteristics of U.S. adults
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits
Few medicines have changed a field the way Wegovy has
Results Over the course of the last year in the overall- and paired populations there was an increase in BMI (median [IQR] 25.7 [22.8-30.0] to 26.7 [23.8-31.1] kg/m2, p=6.4x10-5 and 26.8 [23.4-31.7] to 27.1 [23.8-31.8] kg/m2, p=3.7x10-4, respectively) and overweight and obesity ([figure 1A][1])
Pills or injections
They also offer the
